Esketamine, commonly known as Spravato, is a remarkable drug that belongs to the class of NMDA receptor antagonists and provides a ground-breaking therapeutic approach. It is aimed at treating treatment-resistant depression, giving those who have not responded to traditional antidepressant therapy a glimpse of hope.
Office Manager
Operationmed
Mckenzie Munkholm
Delacruz Noble
Inmybowl Health And Wellness
Goode Rutledge
Ballard Niemann
Lomholt Malling
Cannabis
Straarup Temple